Catheter Precision authorizes Series C-3 preferred stock issuance
Catheter Precision's board authorized up to 3,470 shares of Series C-3 convertible preferred stock. The designation establishes voting and conversion rights for the new equity class.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day